ARCHIVES

Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects

This article is from The Cancer Letter archive.

Vol. 34 No. 12 | December 30, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

NCI Appropriations, Authorization Bills Passed By House

September 5, 1980

In Brief: Eyre ACS President, Freeman President Elects, Kathleen Horsch Chairman, Davis Heads ASTRO

November 20, 1987

Obey Says NCI “Must Do Better,” Response Dispute GAO Conclusion

August 8, 1980

Fisher, interim NSABP Leadership Enter Third Day Of Negotiations To Settle Suit, Aver Court Battle

September 30, 1994